CA2008772A1 - Dispositif prophylactique oral contre les infections fungi et methode d'utilisation - Google Patents

Dispositif prophylactique oral contre les infections fungi et methode d'utilisation

Info

Publication number: CA2008772A1
Authority: CA; Canada
Prior art keywords: varnish composition; oral; composition; group; varnish
Prior art date: 1989-01-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2008772

Other languages

English (en)

Inventor

Michael Friedman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Yissum Research Development Co of Hebrew University of Jerusalem

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-31

Filing date

1990-01-29

Publication date

1990-07-31

1990-01-29 Application filed by Individual filed Critical Individual

1990-07-31 Publication of CA2008772A1 publication Critical patent/CA2008772A1/fr

Status Abandoned legal-status Critical Current

Links

229940121375 antifungal agent Drugs 0.000 title claims abstract description 30
238000000034 method Methods 0.000 title claims abstract description 30
230000000843 anti-fungal effect Effects 0.000 title claims abstract description 12
239000000203 mixture Substances 0.000 claims abstract description 70
210000000214 mouth Anatomy 0.000 claims abstract description 32
208000015181 infectious disease Diseases 0.000 claims abstract description 30
238000013268 sustained release Methods 0.000 claims abstract description 23
239000012730 sustained-release form Substances 0.000 claims abstract description 23
229920000642 polymer Polymers 0.000 claims abstract description 21
239000000853 adhesive Substances 0.000 claims abstract description 6
230000001070 adhesive effect Effects 0.000 claims abstract description 6
239000004014 plasticizer Substances 0.000 claims abstract description 6
239000002966 varnish Substances 0.000 claims description 34
239000003429 antifungal agent Substances 0.000 claims description 31
229960000988 nystatin Drugs 0.000 claims description 19
VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 claims description 19
239000001856 Ethyl cellulose Substances 0.000 claims description 12
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 12
235000019325 ethyl cellulose Nutrition 0.000 claims description 12
229920001249 ethyl cellulose Polymers 0.000 claims description 12
241000222120 Candida <Saccharomycetales> Species 0.000 claims description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
241000222122 Candida albicans Species 0.000 claims description 9
208000006819 Denture Stomatitis Diseases 0.000 claims description 9
229920001223 polyethylene glycol Polymers 0.000 claims description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
229920000175 Pistacia lentiscus Polymers 0.000 claims description 6
239000002202 Polyethylene glycol Substances 0.000 claims description 6
241001465754 Metazoa Species 0.000 claims description 5
229920001600 hydrophobic polymer Polymers 0.000 claims description 5
APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 4
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 4
229960003942 amphotericin b Drugs 0.000 claims description 4
239000003795 chemical substances by application Substances 0.000 claims description 4
229940095731 candida albicans Drugs 0.000 claims description 3
-1 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 claims description 2
239000000020 Nitrocellulose Substances 0.000 claims description 2
239000004677 Nylon Substances 0.000 claims description 2
239000004698 Polyethylene Substances 0.000 claims description 2
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 2
241000222126 [Candida] glabrata Species 0.000 claims description 2
229960004022 clotrimazole Drugs 0.000 claims description 2
VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims description 2
239000003086 colorant Substances 0.000 claims description 2
238000007598 dipping method Methods 0.000 claims description 2
239000005038 ethylene vinyl acetate Substances 0.000 claims description 2
229960002509 miconazole Drugs 0.000 claims description 2
239000002480 mineral oil Substances 0.000 claims description 2
235000010446 mineral oil Nutrition 0.000 claims description 2
229920001220 nitrocellulos Polymers 0.000 claims description 2
229920001778 nylon Polymers 0.000 claims description 2
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 2
229920000193 polymethacrylate Polymers 0.000 claims description 2
229920001296 polysiloxane Polymers 0.000 claims description 2
239000000600 sorbitol Substances 0.000 claims description 2
239000007921 spray Substances 0.000 claims description 2
239000004094 surface-active agent Substances 0.000 claims description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
235000019441 ethanol Nutrition 0.000 claims 1
239000000796 flavoring agent Substances 0.000 claims 1
235000013355 food flavoring agent Nutrition 0.000 claims 1
230000002265 prevention Effects 0.000 abstract description 6
150000001875 compounds Chemical class 0.000 abstract description 4
230000009469 supplementation Effects 0.000 abstract 1
239000003814 drug Substances 0.000 description 24
229940079593 drug Drugs 0.000 description 23
238000011282 treatment Methods 0.000 description 20
210000000515 tooth Anatomy 0.000 description 17
201000003984 candidiasis Diseases 0.000 description 14
238000009472 formulation Methods 0.000 description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
230000007774 longterm Effects 0.000 description 10
210000001519 tissue Anatomy 0.000 description 9
201000010099 disease Diseases 0.000 description 8
230000000694 effects Effects 0.000 description 8
240000005428 Pistacia lentiscus Species 0.000 description 7
230000005764 inhibitory process Effects 0.000 description 7
239000003242 anti bacterial agent Substances 0.000 description 6
230000001857 anti-mycotic effect Effects 0.000 description 6
239000002543 antimycotic Substances 0.000 description 6
241000233866 Fungi Species 0.000 description 5
208000031888 Mycoses Diseases 0.000 description 5
208000007027 Oral Candidiasis Diseases 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
238000011156 evaluation Methods 0.000 description 5
230000002538 fungal effect Effects 0.000 description 5
239000013521 mastic Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
238000002560 therapeutic procedure Methods 0.000 description 5
239000013543 active substance Substances 0.000 description 4
230000001684 chronic effect Effects 0.000 description 4
239000007937 lozenge Substances 0.000 description 4
239000000463 material Substances 0.000 description 4
239000002324 mouth wash Substances 0.000 description 4
235000010603 pastilles Nutrition 0.000 description 4
210000003800 pharynx Anatomy 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
239000002904 solvent Substances 0.000 description 4
230000002459 sustained effect Effects 0.000 description 4
230000009885 systemic effect Effects 0.000 description 4
206010007134 Candida infections Diseases 0.000 description 3
206010017533 Fungal infection Diseases 0.000 description 3
206010048685 Oral infection Diseases 0.000 description 3
241000287411 Turdidae Species 0.000 description 3
239000012871 anti-fungal composition Substances 0.000 description 3
235000019658 bitter taste Nutrition 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000000576 coating method Methods 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
230000003902 lesion Effects 0.000 description 3
239000002609 medium Substances 0.000 description 3
210000004877 mucosa Anatomy 0.000 description 3
230000007406 plaque accumulation Effects 0.000 description 3
210000003296 saliva Anatomy 0.000 description 3
241000894007 species Species 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
208000030507 AIDS Diseases 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
201000007336 Cryptococcosis Diseases 0.000 description 2
241000221204 Cryptococcus neoformans Species 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
206010061598 Immunodeficiency Diseases 0.000 description 2
208000029462 Immunodeficiency disease Diseases 0.000 description 2
208000001388 Opportunistic Infections Diseases 0.000 description 2
201000007100 Pharyngitis Diseases 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
239000002998 adhesive polymer Substances 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
229960001927 cetylpyridinium chloride Drugs 0.000 description 2
YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
229960003260 chlorhexidine Drugs 0.000 description 2
238000011443 conventional therapy Methods 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000002939 deleterious effect Effects 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
239000012530 fluid Substances 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
239000003906 humectant Substances 0.000 description 2
229920001477 hydrophilic polymer Polymers 0.000 description 2
230000007813 immunodeficiency Effects 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
210000002200 mouth mucosa Anatomy 0.000 description 2
229940051866 mouthwash Drugs 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
230000003239 periodontal effect Effects 0.000 description 2
229920000058 polyacrylate Polymers 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
238000010186 staining Methods 0.000 description 2
208000003265 stomatitis Diseases 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
210000003371 toe Anatomy 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
BLSQLHNBWJLIBQ-OZXSUGGESA-N (2R,4S)-terconazole Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2N=CN=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 BLSQLHNBWJLIBQ-OZXSUGGESA-N 0.000 description 1
MPIPASJGOJYODL-SFHVURJKSA-N (R)-isoconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 MPIPASJGOJYODL-SFHVURJKSA-N 0.000 description 1
AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 1
OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 1
QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 description 1
VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
241000235389 Absidia Species 0.000 description 1
201000000674 African histoplasmosis Diseases 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
201000002909 Aspergillosis Diseases 0.000 description 1
208000036641 Aspergillus infections Diseases 0.000 description 1
241000335423 Blastomyces Species 0.000 description 1
206010005098 Blastomycosis Diseases 0.000 description 1
241000222178 Candida tropicalis Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
206010008803 Chromoblastomycosis Diseases 0.000 description 1
208000015116 Chromomycosis Diseases 0.000 description 1
241000222290 Cladosporium Species 0.000 description 1
241000223205 Coccidioides immitis Species 0.000 description 1
241000518994 Conta Species 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
206010012504 Dermatophytosis Diseases 0.000 description 1
208000017701 Endocrine disease Diseases 0.000 description 1
206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
201000003950 Geotrichosis Diseases 0.000 description 1
244000168141 Geotrichum candidum Species 0.000 description 1
235000017388 Geotrichum candidum Nutrition 0.000 description 1
208000005232 Glossitis Diseases 0.000 description 1
206010018691 Granuloma Diseases 0.000 description 1
241000228402 Histoplasma Species 0.000 description 1
241000228404 Histoplasma capsulatum Species 0.000 description 1
201000002563 Histoplasmosis Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
244000285963 Kluyveromyces fragilis Species 0.000 description 1
201000008197 Laryngitis Diseases 0.000 description 1
206010067125 Liver injury Diseases 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical group CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
241001460074 Microsporum distortum Species 0.000 description 1
241000235395 Mucor Species 0.000 description 1
101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
206010060860 Neurological symptom Diseases 0.000 description 1
CANCCLAKQQHLNK-LSDHHAIUSA-N O-[[(1R,8S)-4-tricyclo[6.2.1.02,7]undeca-2(7),3,5-trienyl]] N-methyl-N-(3-methylphenyl)carbamothioate Chemical compound CN(C(=S)Oc1ccc2[C@H]3CC[C@H](C3)c2c1)c1cccc(C)c1 CANCCLAKQQHLNK-LSDHHAIUSA-N 0.000 description 1
208000025157 Oral disease Diseases 0.000 description 1
206010061324 Oral fungal infection Diseases 0.000 description 1
206010068319 Oropharyngeal pain Diseases 0.000 description 1
206010033767 Paracoccidioides infections Diseases 0.000 description 1
201000000301 Paracoccidioidomycosis Diseases 0.000 description 1
241000222831 Phialophora <Chaetothyriales> Species 0.000 description 1
241000235645 Pichia kudriavzevii Species 0.000 description 1
229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
201000004328 Pulpitis Diseases 0.000 description 1
206010037464 Pulpitis dental Diseases 0.000 description 1
241000022563 Rema Species 0.000 description 1
241000223667 Rhinocladiella Species 0.000 description 1
241000293824 Rhinosporidium seeberi Species 0.000 description 1
241000235527 Rhizopus Species 0.000 description 1
241000235343 Saccharomycetales Species 0.000 description 1
241001149962 Sporothrix Species 0.000 description 1
206010041736 Sporotrichosis Diseases 0.000 description 1
208000002474 Tinea Diseases 0.000 description 1
108010077913 Triamcinolone Acetonide Drug Combination Nystatin Neomycin Sulfate Gramicidin Proteins 0.000 description 1
241000223238 Trichophyton Species 0.000 description 1
241000223229 Trichophyton rubrum Species 0.000 description 1
241001480048 Trichophyton tonsurans Species 0.000 description 1
241001480050 Trichophyton violaceum Species 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229960003093 antiseptics and disinfectants Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
210000001142 back Anatomy 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
229960002206 bifonazole Drugs 0.000 description 1
239000006161 blood agar Substances 0.000 description 1
230000001680 brushing effect Effects 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000002775 capsule Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
230000008859 change Effects 0.000 description 1
208000007287 cheilitis Diseases 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
230000007012 clinical effect Effects 0.000 description 1
239000012568 clinical material Substances 0.000 description 1
201000003486 coccidioidomycosis Diseases 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
208000002925 dental caries Diseases 0.000 description 1
239000000551 dentifrice Substances 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
231100000676 disease causative agent Toxicity 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
208000030172 endocrine system disease Diseases 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
229960004884 fluconazole Drugs 0.000 description 1
RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
229960004413 flucytosine Drugs 0.000 description 1
230000037406 food intake Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
208000007565 gingivitis Diseases 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000005802 health problem Effects 0.000 description 1
208000013210 hematogenous Diseases 0.000 description 1
231100000234 hepatic damage Toxicity 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
230000002390 hyperplastic effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
208000014674 injury Diseases 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
229960004849 isoconazole Drugs 0.000 description 1
229960004130 itraconazole Drugs 0.000 description 1
210000001847 jaw Anatomy 0.000 description 1
229960004125 ketoconazole Drugs 0.000 description 1
210000000867 larynx Anatomy 0.000 description 1
230000008818 liver damage Effects 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
238000002483 medication Methods 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
229960004313 naftifine Drugs 0.000 description 1
OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
239000000820 nonprescription drug Substances 0.000 description 1
150000004010 onium ions Chemical class 0.000 description 1
229960003483 oxiconazole Drugs 0.000 description 1
QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 description 1
238000010422 painting Methods 0.000 description 1
210000003254 palate Anatomy 0.000 description 1
210000002741 palatine tonsil Anatomy 0.000 description 1
239000006072 paste Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
208000028169 periodontal disease Diseases 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
150000004291 polyenes Chemical class 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
125000001453 quaternary ammonium group Chemical group 0.000 description 1
239000013557 residual solvent Substances 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
210000004761 scalp Anatomy 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000007905 soft elastic gelatin capsule Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
229960002799 stannous fluoride Drugs 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
229960002607 sulconazole Drugs 0.000 description 1
235000019640 taste Nutrition 0.000 description 1
229960002722 terbinafine Drugs 0.000 description 1
DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
229960000580 terconazole Drugs 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229960004214 tioconazole Drugs 0.000 description 1
229960003916 tolciclate Drugs 0.000 description 1
229960004880 tolnaftate Drugs 0.000 description 1
FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
206010044008 tonsillitis Diseases 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CA 2008772 1989-01-31 1990-01-29 Dispositif prophylactique oral contre les infections fungi et methode d'utilisation Abandoned CA2008772A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US30409289A	1989-01-31	1989-01-31
US304,092		1989-01-31
US465,786		1990-01-18

Publications (1)

Publication Number	Publication Date
CA2008772A1 true CA2008772A1 (fr)	1990-07-31

Family

ID=23175014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2008772 Abandoned CA2008772A1 (fr)	1989-01-31	1990-01-29	Dispositif prophylactique oral contre les infections fungi et methode d'utilisation

Country Status (1)

Country	Link
CA (1)	CA2008772A1 (fr)

1990
- 1990-01-29 CA CA 2008772 patent/CA2008772A1/fr not_active Abandoned

Legal Events

Date	Code	Title	Description
1997-01-16	EEER	Examination request
2002-01-29	FZDE	Dead

Publication	Publication Date	Title
EP0381446B1 (fr)	1994-08-10	Compositions pour utilisation orale à activité fongicide
US5438076A (en)	1995-08-01	Liquid polymer composition, and method of use
US5160737A (en)	1992-11-03	Liquid polymer composition, and method of use
US4496322A (en)	1985-01-29	Benzoin antimicrobial dental varnishes
US4981875A (en)	1991-01-01	Medicaments for the region of the oral cavity
US5139768A (en)	1992-08-18	Dental composition for hypersensitive teeth
RU2301056C2 (ru)	2007-06-20	Жидкая полимерная композиция для предотвращения и лечения заболеваний полости рта
US10843013B2 (en)	2020-11-24	Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders
JPH09503504A (ja)	1997-04-08	成人歯周炎の治療のためのアジトロマイシンの用途とこの用途のための局所組成物
Steinberg et al.	1999	Dental drug-delivery devices: local and sustained-release applications
EP0381445B2 (fr)	1998-01-28	Composition dentaire pour les dents hypersensibles
AU2006206252B2 (en)	2009-11-05	Methods and compositions for decreasing saliva production
TWI895312B (zh)	2025-09-01	口腔內黏膜被覆用抗炎性液狀組成物、及使用其之口內炎之預防及/或治療用醫藥組成物
CA2008772A1 (fr)	1990-07-31	Dispositif prophylactique oral contre les infections fungi et methode d'utilisation
RU2852444C1 (ru)	2025-12-08	Стоматологический гель-бандаж
JPS62223114A (ja)	1987-10-01	徐放性歯周病治療剤